Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Invasive Fungal Infections 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

posaconazole 2fludarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1eltrombopag 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Micafungin 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Cytarabine 1Cholecalciferol 1Bone Marrow Transplantation 1Azacitidine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Myelodysplastic Syndromes × Micafungin × Clear all
NCT01200355 2018-05-07

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Memorial Sloan Kettering Cancer Center

Phase 4 Completed
113 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡